The necrotizing enterocolitis drugs market is projected to grow significantly, driven by the rising incidence of NEC in neonates, advancements in antibiotic and antifungal therapies, and increased adoption of parenteral nutrition in neonatal intensive care units. https://www.datamintelligence.com/research-report/listeriosis-market